Nav: Home

Researchers block protein that plays a key role in Alzheimer's disease

May 15, 2019

In recent years, it has become increasingly clear to researchers that the protein galectin-3 is involved in inflammatory diseases in the brain. A study led by researchers at Lund University in Sweden now shows the de facto key role played by the protein in Alzheimer's disease. When the researchers shut off the gene that produces this protein in mice, the amount of Alzheimer's plaque and the inflammatory load both decreased.

Researchers at Lund University together with colleagues in Spain and the UK have published a study in Acta Neuropathologica which reinforces the picture of the relevant protein, galectin-3, as a key player in Alzheimer's disease. Among other things, Alzheimer's disease involves the accumulation of amyloid plaques outside cells and tau protein forming lumps within nerve cells. When our innate immune defence system discovers the plaques, the brain's immune response is activated. It is in precisely this mechanism that the galectin-3 protein appears to play a major role.

"The problem is that if this inflammatory response goes on for a long time, it creates a toxic environment which eventually leads to the breakdown and death of the nerve cells - and the onset of disease", explains Antonio Boza-Serrano at Lund University's experimental neuro-inflammation laboratory, one of the researchers behind the study.

The protein that the researchers investigated is produced by the brain's sanitation workers, the microglial cells, whose care of the brain's immune system includes cleaning out harmful proteins that accumulate in the brain. It seems that galectin-3 is required to activate the microglial cells in the case of plaque formation in the brain.

"We have found that this inflammatory protein increases tenfold in the brains of deceased patients with Alzheimer's disease, and we especially find it in the microglial cells that accumulate around the amyloid plaques", says Antonio Boza-Serrano.

The protein is only present in diseased brains

Galectin-3 is also involved in inflammation in the case of Parkinson's disease and after a stroke. The fact that the protein is barely detectable in healthy brains but increases in cases of inflammation is good from a drug perspective, according to the researchers, as they do not want to risk a drug affecting cells other than those specifically responsible for the development of the disease. It is indeed possible to slow the effect of galectin-3 by using inhibitors that prevent the protein from being active in inflammation.

"We grew microglial cells in the lab and added the protein present in Alzheimer's plaques, which made the cells become very active from an inflammation perspective. But when we added the galectin-3 inhibitors, the microglial cells became 'milder', less inflammatory", explains Tomas Deierborg, head of research at the experimental neuro-inflammation laboratory at Lund University and last author of the study.

Alzheimer's mice without Galectin-3 did better in the labyrinth

The researchers were also able to study mice with Alzheimer's but lacking the gene that produces the galectin-3 protein. They observed that these mice did not develop as much inflammation as those with both Alzheimer's disease and the galectin-3 gene.

"We use a labyrinth out of which the mice have to find their way and we observed that the mice with Alzheimer's but with no galectin-3 were smarter - had a better memory - than the mice with Alzheimer's and galectin-3."

Although the clinical results are promising, the researchers point out that the studies in which they inhibited the protein are conducted on cells, and the studies on the lack of the galectin-3-gene are conducted on mice.

"We have shown that by removing galectin-3, we can decrease the amount of plaque and inflammation in the mice, but we have not studied whether this works in humans. There is every reason to continue and to investigate this further. Although it is a long way to the patient, our hope is that our research findings can lead to future treatments for Alzheimer's disease in people as well", says Tomas Deierborg.
-end-


Lund University

Related Nerve Cells Articles:

How hearing loss can change the way nerve cells are wired
Even short-term blockages in hearing can lead to remarkable changes in the auditory system, altering the behavior and structure of nerve cells that relay information from the ear to the brain, according to a new University at Buffalo study.
Lab-grown nerve cells make heart cells throb
Researchers at Johns Hopkins report that a type of lab-grown human nerve cells can partner with heart muscle cells to stimulate contractions.
Nerve-insulating cells more diverse than previously thought
Oligodendrocytes, a type of brain cell that plays a crucial role in diseases such as multiple sclerosis, are more diverse than have previously been thought, according to a new study by researchers at Karolinska Institutet in Sweden.
Aggregated protein in nerve cells can cause ALS
Persons with the serious disorder ALS, can have a genetic mutation that causes the protein SOD1 to aggregate in motor neurons in the brain and spinal cord.
Aggression causes new nerve cells to be generated in the brain
A group of neurobiologists from Russia and the USA, including Dmitry Smagin, Tatyana Michurina, and Grigori Enikolopov from Moscow Institute of Physics and Technology, have proven experimentally that aggression has an influence on the production of new nerve cells in the brain.
More Nerve Cells News and Nerve Cells Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Teaching For Better Humans
More than test scores or good grades — what do kids need to prepare them for the future? This hour, guest host Manoush Zomorodi and TED speakers explore how to help children grow into better humans, in and out of the classroom. Guests include educators Olympia Della Flora and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#535 Superior
Apologies for the delay getting this week's episode out! A technical glitch slowed us down, but all is once again well. This week, we look at the often troubling intertwining of science and race: its long history, its ability to persist even during periods of disrepute, and the current forms it takes as it resurfaces, leveraging the internet and nationalism to buoy itself. We speak with Angela Saini, independent journalist and author of the new book "Superior: The Return of Race Science", about where race science went and how it's coming back.